Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it

How 1 sources are covering this

• CNBCLean R·2h ago

  Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it

  Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same as 2025 and up from 34% in 2024, the survey said.

  Read at CNBC →